HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vance, B. A. Articles by Kearse, K. P. Search for Related Content PubMed PubMed Citation Articles by Vance, B. A. Articles by Kearse, K. P. Social Bookmarking                      What's this?

Volume 272, Number 37, Issue of September 12, 1997 pp. 23117-23122
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Multiple Dimeric Forms of Human CD69 Result from Differential Addition of N-Glycans to Typical (Asn-X-Ser/Thr) and Atypical (Asn-X-Cys) Glycosylation Motifs

(Received for publication, June 20, 1997)

Barbara A. Vance , Wenyu Wu , Randall K. Ribaudo , David M. Segal and Kelly P. Kearse ^§

From the Experimental Immunology Branch and  Laboratory of Immune Cell Biology, NCI, National Institutes of Health, Bethesda, Maryland 20892-1360 and ^§ Department of Microbiology and Immunology, East Carolina University, School of Medicine, Greenville, North Carolina 27858-3454

CD69 is expressed on the surface of all hematopoietically derived leukocytes and is suggested to function as a multipurpose cell-surface trigger molecule important in the development and activation of many different cell types. Human CD69 contains only a single consensus sequence for N-linked oligosaccharide addition within its extracellular domain (Asn-Val-Thr), yet exists as two distinct glycoforms that are assembled together into disulfide-linked homodimers and heterodimers. The molecular basis for human CD69 heterogeneity has remained elusive. In the current report we show that human CD69 glycoforms are generated before the egress of CD69 proteins from the endoplasmic reticulum to the Golgi and are synthesized under conditions where Golgi processing is inhibited, effectively ruling out the possibility that CD69 heterogeneity results from the differential processing of a single glycosylation site in the Golgi complex. Importantly, these data demonstrate that contrary to current belief, not one but two sites for N-glycan addition exist within the human CD69 extracellular domain and identify the second, "cryptic" CD69 N-glycan attachment site as the atypical Cys-containing glycosylation motif, Asn-Ala-Cys. The results in this study provide a molecular basis for human CD69 heterogeneity and show that multiple dimeric forms of human CD69 result from the variable addition of N-glycans to atypical and typical glycosylation motifs within the CD69 extracellular domain.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Oostra, E. G. te Lintelo, M. Deijs, M. H. Verheije, P. J. M. Rottier, and C. A. M. de Haan Localization and Membrane Topology of Coronavirus Nonstructural Protein 4: Involvement of the Early Secretory Pathway in Replication J. Virol., November 15, 2007; 81(22): 12323 - 12336. [Abstract] [Full Text] [PDF]

				N. E. Davey, D. C. Shields, and R. J. Edwards SLiMDisc: short, linear motif discovery, correcting for common evolutionary descent Nucleic Acids Res., July 19, 2006; 34(12): 3546 - 3554. [Abstract] [Full Text] [PDF]

				M. Haniu, T. Arakawa, E. J. Bures, Y. Young, J. O. Hui, M. F. Rohde, A. A. Welcher, and T. Horan Human Leptin Receptor. DETERMINATION OF DISULFIDE STRUCTURE AND N-GLYCOSYLATION SITES OF THE EXTRACELLULAR DOMAIN J. Biol. Chem., October 30, 1998; 273(44): 28691 - 28699. [Abstract] [Full Text] [PDF]